Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens.

Published in: Journal of gynecologic oncology (2018)

Chemotherapeutic regimens with taxane could be recommended for early-stage OC patients >50 years of age.

Keyphrases